Molecular Decisions (MDI) is an oncology diagnostic company focused on developing proteomics-based assays that provide physicians with real-time information to direct their clinical decision-making and provide the best-personalized care. Our unique proteomic platform measures modifications occurring to protein targets of therapeutic agents which can predict therapeutic drug efficacy and positive patient outcomes.
Company Details
- Employees
- 5
- Address
- 1230 Bordeaux Dr, Sunnyvale,california 94089,united States
- Industry
- Biotechnology
- Website
- molecular-decisions.com
- HQ
- Sunnyvale, California
Molecular Decisions Questions
Molecular Decisions's website is molecular-decisions.com
Molecular Decisions's LinkedIn profile is https://www.linkedin.com/company/moleculardecisions
Molecular Decisions has
5 employees.
View email and phone details for 5
employees at Molecular Decisions.
Molecular Decisions's industry is
Biotechnology
Molecular Decisions's top competitors are
Karamedica, Inc.,
Cinnagen,
Adorateb,
Guangdong Techpool Biochemical Pharmaceutical Co., Ltd.,
Gempharmatech,
Molecular Depot Llc,
Elefsee Pharmaceuticals International, Ltd,
Neucyte,
Biopanda Diagnostics,
Adooq Bioscience Llc.
Molecular Decisions's categories are Biotechnology
